ATEM Capital
Overview
ATEM Capital is a New York-based venture capital firm founded in 2014 that specializes in early, late-stage, and growth capital investments within the life sciences sector . The firm primarily targets the biotechnology and pharmaceuticals fields, allocating 70% of its investments to these areas, which includes a focus on early-stage and late-stage assets. Additionally, it invests in de-risked medical devices and diagnostics, accounting for the remaining 30% of its portfolio . ATEM Capital is particularly interested in life-saving and life-changing technologies, including those related to oncology, cardiovascular health, anti-infectives, CNS/pain management, and women's health .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arpeggio Biosciences | Sep 2022 | Series A | Co-investor |
| Epic Sciences | Sep 2018 | Series E | Co-investor |
| Iridia, Inc. | Mar 2021 | Series B | Co-investor |
| Walden Biosciences | Oct 2020 | Series A | - |
| Triumvira Immunologics | Mar 2022 | Series A Extension | - |
For institutional investors. Book with your work email.
Key People
Allan Gobbs
Co-Founder & Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ATEM Capital based?
ATEM Capital is headquartered in New York City, New York, United States.
When was ATEM Capital founded?
ATEM Capital was founded in 2014.
How many portfolio companies does ATEM Capital have?
ATEM Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in ATEM Capital's portfolio?
Portfolio companies visible on Caplight include Arpeggio Biosciences, Epic Sciences, Iridia, Inc., Walden Biosciences, Triumvira Immunologics.
What was ATEM Capital's most recent investment shown here?
ATEM Capital's most recent investment in this portfolio sample was in Arpeggio Biosciences in 2022.
What sectors does ATEM Capital focus on?
ATEM Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does ATEM Capital focus on?
ATEM Capital typically invests at the Early stage.
What is ATEM Capital's AUM?
ATEM Capital's assets under management are estimated between $100.0M and $250.0M.